Assignee profile:

BIOTEST AG

City:

Dreieich

Country:

Germany

Published Applications:

39

Last publication date:

2024-01-11

Patent Grants:

36

Last grant date:

2025-04-01

Top Inventors for applications by BIOTEST AG

These are the the leading inventors for applications assigned to BIOTEST AG:

Recent patent applications by BIOTEST AG

BIOTEST AG based in Dreieich, DE has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2024-01-11 ✅ Patent 12,264,191 granted on 2025-04-01
US20240010707A1
Chemistry; metallurgy

De-immunized factor VIII molecule and pharmaceutical compositions comprising the same

#2 | 2023-08-03 ✅ Patent 12,186,391 granted on 2025-01-07
US20230241210A1
Human necessities

Treatment of severe community acquired pneumonia

#3 | 2022-07-21 ✅ Patent 12,487,244 granted on 2025-12-02
US20220229069A1
Physics

METHOD AND KIT FOR TESTING POTENCY OF IMMUNOGLOBULIN COMPOSITIONS

#4 | 2021-06-17 ✅ Patent 11,780,909 granted on 2023-10-10
US20210179694A1
Chemistry; metallurgy

Methods of treating viral infections by administering an antibody preparation comprising IGG, IGA and IGM

#5 | 2021-06-03 ✅ Patent 11,517,621 granted on 2022-12-06
US20210162043A1
Human necessities

Treatment of severe community acquired pneumonia

#6 | 2020-08-27 ✅ Patent 10,918,715 granted on 2021-02-16
US20200268881A1
Human necessities

Treatment of severe community acquired pneumonia

#7 | 2019-05-30 ✅ Patent 11,325,964 granted on 2022-05-10
US20190161533A1
Chemistry; metallurgy

Process for preparing immunoglobulin compositions

#8 | 2019-04-25
US20190117770A1
Human necessities

USES OF IMMUNOCONJUGATES TARGETING CD138

#9 | 2018-11-08 ✅ Patent 10,954,290 granted on 2021-03-23
US20180319871A1
Chemistry; metallurgy

IgG, IgA and IgM antibody preparations, method of making and method of use in treatment

#10 | 2017-03-02 ✅ Patent 10,059,759 granted on 2018-08-28
US20170058020A1
Chemistry; metallurgy

Antibody preparations

#11 | 2015-08-06 ✅ Patent 9,540,436 granted on 2017-01-10
US20150218270A1
Chemistry; metallurgy

Use of antibodies for detection of IL-10

#12 | 2015-03-05 ✅ Patent 9,605,066 granted on 2017-03-28
US20150064179A1
Chemistry; metallurgy

Humanized anti-IL-10 antibodies for the treatment of systemic lupus erythematosus (SLE)

#13 | 2015-03-05 ✅ Patent 9,518,110 granted on 2016-12-13
US20150064170A1
Chemistry; metallurgy

Antibody preparations

#14 | 2014-08-07 ✅ Patent 9,758,581 granted on 2017-09-12
US20140220008A1
Chemistry; metallurgy

Humanized anti-CD4 antibody with immunosuppressive properties

#15 | 2014-01-09 ✅ Patent 10,117,932 granted on 2018-11-06
US20140010828A1
Human necessities

Uses of immunoconjugates targeting CD138

#16 | 2013-02-28 ✅ Patent 9,243,056 granted on 2016-01-26
US20130052208A1
Chemistry; metallurgy

Process for preparing an immunoglobulin composition

#17 | 2013-02-21 ✅ Patent 8,900,806 granted on 2014-12-02
US20130045199A1
Chemistry; metallurgy

Antibody preparations

#18 | 2013-01-03 ✅ Patent 9,995,733 granted on 2018-06-12
US20130004513A1
Physics

Agents for treating disease

#19 | 2012-12-20 ✅ Patent 8,852,871 granted on 2014-10-07
US20120321618A1
Chemistry; metallurgy

Humanized anti-IL-10 antibodies for the treatment of systemic lupus erythematosus (SLE)

#20 | 2012-12-20 ✅ Patent 8,956,607 granted on 2015-02-17
US20120321617A1
Chemistry; metallurgy

Humanized anti-IL 10 antibodies for the treatment of systemic lupus erythematosus (SLE)

#21 | 2011-05-26 ✅ Patent 9,289,509 granted on 2016-03-22
US20110123554A1
Human necessities

Uses of immunoconjugates targeting CD138

#22 | 2011-03-10 ✅ Patent 9,334,325 granted on 2016-05-10
US20110059084A1
Chemistry; metallurgy

Method for treating psoriasis

#23 | 2011-03-10 ✅ Patent 9,550,831 granted on 2017-01-24
US20110059083A1
Chemistry; metallurgy

Method for treating psoriasis

#24 | 2011-03-10 ✅ Patent 9,512,226 granted on 2016-12-06
US20110059082A1
Chemistry; metallurgy

Agent for treating disease

#25 | 2010-11-18 ✅ Patent 8,440,806 granted on 2013-05-14
US20100291676A1
Chemistry; metallurgy

Humanized anti-CD4 antibody with immunosuppressive properties

#26 | 2010-05-27
US20100129784A1
Human necessities

PERFUSION DEVICE FOR HOLLOW ORGANS, AND THE USE THEREOF FOR THE PERFUSION OF AN EXPLANTED HOLLOW ORGAN

#27 | 2009-09-24
US20090237659A1
Physics

High Throughput Particle Counter

#28 | 2009-09-17 ✅ Patent 9,387,261 granted on 2016-07-12
US20090232810A1
Chemistry; metallurgy

Immunoconjugates targeting CD138 and uses thereof

#29 | 2009-08-20 ✅ Patent 8,685,651 granted on 2014-04-01
US20090208497A1
Chemistry; metallurgy

Method for screening for an anti-CD4 antibody suitable for use in immunotherapy

#30 | 2009-08-20 ✅ Patent 8,673,304 granted on 2014-03-18
US20090208496A1
Chemistry; metallurgy

Humanized anti-CD4 antibody with immunosuppressive properties

#31 | 2009-07-16 ✅ Patent 9,011,864 granted on 2015-04-21
US20090181038A1
Chemistry; metallurgy

Method of decreasing cytotoxic side-effects and improving efficacy of immunoconjugates

#32 | 2009-07-09 ✅ Patent 9,221,914 granted on 2015-12-29
US20090175863A1
Chemistry; metallurgy

Agents targeting CD138 and uses thereof

#33 | 2009-07-02 ✅ Patent 9,446,146 granted on 2016-09-20
US20090169570A1
Human necessities

Methods and agents for improving targeting of CD138 expressing tumor cells

#34 | 2009-04-23 ✅ Patent 8,586,715 granted on 2013-11-19
US20090104190A1
Chemistry; metallurgy

Humanized anti-CD4 antibody with immunosuppressive properties

#35 | 2007-08-30 ✅ Patent 7,863,420 granted on 2011-01-04
US20070203330A1
Chemistry; metallurgy

Process for removing fibronectin from plasma fractions

#36 | 2007-08-09 ✅ Patent 8,840,898 granted on 2014-09-23
US20070183971A1
Human necessities

Immunoconjugates targeting syndecan-1 expressing cells and use thereof

#37 | 2007-06-14 ✅ Patent 7,659,247 granted on 2010-02-09
US20070135619A1
Chemistry; metallurgy

Production of a von Willebrand factor preparation having a high specific activity

#38 | 2006-03-09 ✅ Patent 7,452,981 granted on 2008-11-18
US20060051346A1
Chemistry; metallurgy

Humanized anti-CD4 antibody with immunosuppressive properties

#39 | 2005-06-21 ✅ Patent 6,908,745 granted on 2005-06-21
US10218224
-

Gamma sterilizable culture medium for the identification of yeasts and fungi

Also check out Biotest AG's (Dreieich, Germany) applicant profile with 17 patent applications submitted.

AssigneeID:

10359 ⎘